Erik Howell, MD
Interventional Cardiology · Livonia, MINPI 1134410970
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $643 of the $975 with a category attached, or 65.9%. 8 manufacturers reported payments, led by Edwards Lifesciences at 48.7% of the total. Reporting peaked in 2019 at $475 and has fallen 81.4% since, to $88 in 2024. That places this record below the midpoint for interventional cardiology clinicians in MI, where the typical reported total is $6,857.
Across 18 payments — averaging $54.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$475
- Boston Scientific$162
- Abiomed$148
- Medtronic$114
- Atricure, Inc.$24
- Cardiovascular Systems Inc.$21
- plus $32 from 2 others
Across 9 payments — averaging $11,405 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$85K
- Pfizer$17K
What the payments were for
- Travel & lodging$33334%
- Food & beverage$64366%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 10 | $475 |
| Boston Scientific | 2 | $162 |
| Abiomed | 1 | $148 |
| Medtronic | 1 | $114 |
| Atricure, Inc. | 1 | $24 |
| Cardiovascular Systems Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$148
- RESOLUTE ONYX$114
How this compares
$975 in reported general payments places this provider in the 10th percentile of 187 interventional cardiology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 349 | $392,141 |
| XareltoRivaroxaban | 52 | $70,004 |
| Repatha SureclickEvolocumab | 22 | $33,714 |
| Metoprolol Succinate | 614 | $11,666 |
| Atorvastatin Calcium | 393 | $7,155 |
| Rosuvastatin Calcium | 210 | $4,015 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 101 | $2,652 |
| ClopidogrelClopidogrel Bisulfate | 152 | $2,545 |
| Losartan Potassium | 195 | $2,420 |
| Lisinopril | 214 | $2,210 |
| Amlodipine Besylate | 226 | $2,191 |
| Spironolactone | 189 | $2,189 |
| Bumetanide | 55 | $1,932 |
| Ezetimibe | 75 | $1,812 |
| Carvedilol | 96 | $1,380 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Livonia
- Amir KakiDetroit$1.8M
- Tamam MohamadDetroit$960K
- Paul GrossmanAnn Arbor$630K
- Jason RicciPetoskey$594K
- Tim FischellKalamazoo$468K
- Mir BasirDetroit$442K
- Amr AbbasBerkley$416K
- Safwan KassasSaginaw$340K
- Vishal GuptaKalamazoo$293K
- Khaldoon AlaswadDetroit$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.